Vigmed AB signs Distribution Agreement for Greece with An. Mavrogenis S.A.
Vigmed AB continues to build their distributor network by signing an agreement with An. Mavrogenis S.A. for the Greek market. A.N. Mavrogenis, established in 1990, is the largest medical device distributor in the Greek market and is actively building their safety product portfolio to complement their current product range. Vigmed’s products fit extremely well with this plan.
To complement the agreements that were recently announced regarding the Scandinavian countries, Vigmed has now signed an exclusive distribution agreement for the Greek market. An. Mavrogenis S.A. will be responsible for introducing the Vigmed brands to this market which has remained largely unconverted to needle-safeproducts to date. As with Vigmed’s other partners, this will be the start of a close sales, marketing and development cooperation.
L-R: Mike Dooley, Sales Director, Europe, Vigmed, Anastasios Mavrogenis, General Manager, An.Mavrogenis S.A., Henrik Olsen, Business Development Director, Vigmed signing the distribution contract.
“Mavrogenis has a great market presence and a significant history of introducing market changing devices in Greece. We are extremely pleased that Vigmed’s products will be used to further build the Mavrogenis business.” says Mike Dooley, Sales Director of Vigmed.
Anastasios Mavrogenis, General Manager of An. Mavrogenis S.A. explains “The Vigmed “safety” products offer a valuable solution to Health Care Professionals when it comes to protecting against needlestick injuries. Through innovation and high quality, they set new safety standards in the Greek market and we consider the Vigmed products as an extra asset for our company in order to meet the needs of our customers.”
The joint product launch in Greece is expected to take place in Q2 of this year, with deliveries taking place from May onwards.
For further information contact:
Vigmed: Chairman of the board, Lennart Holm +46 70-630 8562 or CEO, Finn Ketler +46 42 600 5311
An.Mavrogenis: General Manager, Anastasios Mavrogenis +30 210 2020 232
Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 15 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.
Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com
An. Mavrogenis S.A. is the biggest medical device distributor in Greece with more than 250 employees. Other An. Mavrogenis S.A. principals include Coloplast, Covidien and Bausch & Lomb.
Tags:
